NCT05297019

A Dosing Study of Hyperbaric Oxygen Therapy (HBOT) on Epigenetic Aging

Hyperbaric Dosage Analysis Effect Of Various PO2 Exposures: Hyperoxia-Hypoxia Paradox On Stem Cell Mobilization, Cell Signaling, Inflammation, Epigenetics & Cell Regeneration

• Status: Unknown
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: 30 (estimated)
• Sponsor: TruDiagnostic · Industry
• Sex: All
• Age: 40 Years – 70 Years
• Healthy volunteers: Accepted

Summary

This study aims to assess the impact of hyperbaric oxygen therapy on a number of outcomes, including epigenetic aging, inflammation, and cellular health.

Detailed description

While current research has identified many mechanisms of action, effects and cell signaling benefits resulting from HBOT, we do not have a firm understanding of the timeframe and dosage for many of these expected adaptations. Data from this study will be collected and shared on an ongoing basis throughout the course of care. This research project will help us to confirm these cell-signaling changes and benefits, and also develop a better understanding of the necessary PO2 and time frame required in order to achieve these changes leading to improved patient outcomes in the field of hyperbaric medicine.

Conditions

• Aging

Interventions

Type	Name	Description
PROCEDURE	Hyperbaric Oxygen Therapy	hyperbaric oxygen therapy

Timeline

• Start date: 2022-03-01
• Primary completion: 2023-04-30
• Completion: 2023-07-01
• First posted: 2022-03-25
• Last updated: 2023-04-12

Locations

1 site across 1 country: United States